One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage Plus
Audio Papers
Ask R Discovery
Translation
Auto-sync
Collaboration
Open Accesshttps://doi.org/10.1016/j.annonc.2021.10.141
Copy DOI
Export
Save
Share
Cite Journal: Annals of Oncology |  Publication Date: Dec 1, 2021 |
 Citations: 10 |  License type: publisher-specific-oa |
Affiliation: German Center for Lung Research, LungenClinic Grosshansdorf, Seoul National University Bundang Hospital, The Maria Sklodowska-Curie National Research Institute of Oncology, Memorial Sloan Kettering Cancer Center, Bristol-Myers Squibb (United States), Fox Chase Cancer Center, Emory University, Hospital Universitario 12 De Octubre, Translational Research Institute, Queensland University of Technology, Princess Alexandra Hospital, Metropolitan Hospital, Japanese Foundation For Cancer Research, Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla, Institute of Oncology Prof. Dr. Ion Chiricuta, University of Lausanne, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Fundación Arturo López Pérez, Johns Hopkins Medicine, Johns Hopkins University, Sidney Kimmel Cancer Center
122MO Nivolumab (NIVO) + ipilimumab (IPI) as first-line (1L) treatment (tx) for patients (pts) with advanced NSCLC (aNSCLC) and baseline (BL) brain metastases (mets): Intracranial and systemic outcomes from CheckMate 227 Part 1
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
